Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer

Clinical trial NCT01296243 · UNKNOWN

Trial details

NCT number: NCT01296243
Sponsor: Genta Incorporated
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2011-02-01
Primary completion: 2012-08-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.